Omada Health (OMDA) Stock: Buy, Sell, or Hold?
OMDA - Omada Health, Inc. Common Stock
$20.41
-0.40 (-1.92%)
▼
5d:
+3.5%
30d:
-10.64%
90d:
-8.84%
HOLD
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When OMDA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: OMDA shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: OMDA shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$27.07
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$16.81
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OMDA is currently trading at $20.41, which is considered fair relative to its 30-day fair value range of $19.84 to $23.24. From a valuation perspective, the stock is trading at a discount (Forward PE: 36.7) compared to its historical average (55.4). Remarkably, the market is currently pricing in an annual earnings decline of 12.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, OMDA is in a uptrend. Immediate support is located at $18.68, while resistance sits at $21.52.
Market Sentiment: OMDA scores 84/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $28.42 (+39.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OMDA is in a uptrend. Immediate support is located at $18.68, while resistance sits at $21.52.
Market Sentiment: OMDA scores 84/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $28.42 (+39.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$19.84 -
$23.24
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
83.3%
Protect Your Profits
Holding OMDA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (84/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 39.2% below Wall St target ($28.42)
- CAUTION: Bottoming setup, but lagging the sector by 25% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$19.84 -
$23.24
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$18.68
Resistance Level
$21.52
Current Trend
Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
36.70
Wall Street Target
$28.42
(+39.2%)
Revenue Growth (YoY)
43.1%
Profit Margin
1.4%
Valuation Discount vs History
-12.8% cheaper
PE vs Historical
36.7 vs 55.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-12.8%
(market-implied from PE analysis)
1-Year Target
$18.37
(-10%)
2-Year Target
$16.53
(-19%)
3-Year Target
$14.88
(-27%)
3-Yr Target (if PE normalizes)
(PE: 37→55)
$22.46
(+10%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 36.7, Growth: 27.5%)
$42.35
(+108%)
Base:
(SPY PE: 20.4, Growth: 27.5%)
$23.54
(+15%)
Bear:
(PE: 17.3, Growth: 27.5%)
$20.01
(-2%)
📈
Valuation based on Current Earnings
Trailing PE: 28.90 | Current EPS (TTM): $0.72
Bull Case
$17.68
(-13%)
Analyst growth -22.8%, PE expands to 31.8
Base Case
$16.07
(-21%)
Market implied -22.8%, PE stable at 28.9
Bear Case
$14.15
(-31%)
Severe decline -20.0%, PE contracts to 24.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 36.7 to 55.4
Stabilization Target:
$30.81
(+50.9%)
PE Expansion Potential:
+50.9%
Share & Embed Analysis
Last updated: October 01, 2026 11:32 PM ET
Data refreshes hourly during market hours. Next update: 12:32 AM
Data refreshes hourly during market hours. Next update: 12:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OMDA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Wei-Li Shao
SELL
2829 shares
2026-04-08
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 60 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 80 BUY |
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$297 | 41 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 56 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 51 HOLD |
Advanced OMDA Option Strategies
Professional options setups generated by AI based on today's OMDA price and gamma walls.